|
|
Article: Clinical Utility of Exhaled Nitric Oxide Highlighted By American Thoracic Society Panel.
- Article from:
- PR Newswire
- Article date:
- June 2, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Panel also addresses limitations of current randomized trials
MENLO PARK, Calif., June 2 /PRNewswire/ -- Apieron, Inc. highlighted recent clinical panel presentations underscoring the positive impact of measuring exhaled nitric oxide (eNO) for treating asthma in adults and children. The company also cited recognition that design and methodology issues led to mixed results in some randomized trials of eNO-guided therapy. Apieron develops and markets non-invasive monitors that measure exhaled nitric oxide (eNO) for better asthma management.
At the American Thoracic Society's recent annual meeting, panelists in a session titled "Understanding Exhaled ...